Gilteritinib
Quick Overview
| Attribute | Value |
|---|---|
| Drug Name | Gilteritinib |
| DrugBank ID | DB12141 |
| KG Predictions | 15 |
| DL Predictions (≥0.7) | 0 |
| Evidence Level | L5 |
| NPRA Status | Approved |
Sample Brand Names in Malaysia
Predicted Indications
This drug has 15 knowledge graph predictions and 0 high-confidence deep learning predictions.
Top KG Predictions
| Indication | Source |
|---|---|
| therapy related acute myeloid leukemia and myelodysplastic syndrome | KG |
| acute myeloblastic leukemia with maturation | KG |
| acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor | KG |
| acute myeloid leukemia with minimal differentiation | KG |
| myeloid leukemia | KG |
| acute myeloid leukemia with t(6;9)(p23;q34) | KG |
| acute myeloid leukemia with t(8;21)(q22;q22) translocation | KG |
| inherited acute myeloid leukemia | KG |
| acute myeloid leukemia with t(8;16)(p11;p13) translocation | KG |
| acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2) | KG |
FHIR Resources
Access drug data via FHIR R4 API:
- MedicationKnowledge:
/fhir/MedicationKnowledge/DB12141
Related Resources
| Resource | Link |
|---|---|
| DrugBank | View on DrugBank |
| PubMed | Search PubMed |
| ClinicalTrials.gov | Search Trials |
Disclaimer
Drug repurposing predictions are for research purposes only. These predictions have not been clinically validated and should not be used for medical decisions. Always consult healthcare professionals.
Drug repurposing predictions are for research purposes only. These predictions have not been clinically validated and should not be used for medical decisions. Always consult healthcare professionals.